Cohort of Patients With Rare Iron Overloads Excluding C282Y Homozygosity (HEPCICOR)

Rennes University Hospital

Status: Completed

Conditions: Rare Iron Overlaods

Treatments: Other: samples with DNA

Study type: Observational

Funder types: Other

Identifiers

NCT02619955

35RC14_9841

Details and patient eligibility

About

The study explores the hepcidin deficiency causes of rare iron overload (excluding C282Y homozygosity), and aim to characterize this iron overload in term of clinical, biological, genetic and functional spacificities.

Full description

Chronic iron overload are responsible for morbidity and mortality. There are many causes, genetic and acquired. Hepcidin deficiency related to genetic desease is one of them.

This study concerns specifically this cause, and seeks to characterize these iron overloads on clinical, biological, genetic and functional point of view.

A significant number of patients with chronic iron overload, present a phenotype of hepcidin deficiency. This profile is characterized by an elevated plasma iron increased serum transferrin saturation, a transferrin saturation, and a parenchyma distribution of iron overload. These diseases either remains unexplained or are associated with mutations in the gene involved in iron metablism regulation.

The main objective of this study is to characterize these iron overloads with phenotype of hepcidin deficiency not related to homozygosity C282Y (clinical, biological and genetic).

Enrollment: 60 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Biological profile suggestive of hepcidin deficiency:

  • increase of transferrin saturation coefficient (> 50 %) verified on at least 2 times, and calculated from the transferrinemia.
  • Proved hepatic iron overload: by the dosage of the iron hepatic concentration either on block hepatic biopsic, or by MRI according to the method of quantification of the iron validated overload (by adopting a threshold of 100 µmol /g)
  • Patient's written consent for examination of genetic characteristics for diagnosis and collection development for genetic and not genetic research within the framework of an abnormality of the iron metabolism
  • Patient written inform consent.

Exclusion criteria

• HFE hemochromatosis: homozygosity C282Y/C282Y
• Treatment with iterative phlebotomy
• Hematologic diseases with dyserythropoiesis and/or repeated transfusions
• Haptoglobin low, below normal directing towards the diagnosis of chronic hemolysis, myelodysplasia
• Prolonged oral or parenteral iron supplementation
• Current or past excessive regular drinking
• Patient minor or under legal protection measure

Trial design

60 participants in 1 patient group

Rare iron overload with hepcidin deficiency

Description:

clinical, biological, and genetic analysis of rare iron overlaod phenotype (except C282Yhomozygisity), samples with DNA

Treatment:

Other: samples with DNA